Filed: 8/14/2024ACC: 0001583977-24-000003
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 49 equity positions with a total reported market value of $1.73B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
49
Positions
$1.73B
Total AUM (reported)
76.91M
Total Shares
Allocation by class
COM$900.40M52.0%
CLASS A ORD$373.49M21.6%
COM NEW$192.39M11.1%
COMMON STOCK$84.16M4.9%
ORDINARY SHARES$51.10M3.0%
COM PAR $.01$45.23M2.6%
SPONSORED ADS$42.71M2.5%
Portfolio Concentration
Top 3$549.28M31.7%
4–10$463.62M26.8%
11–25$484.55M28.0%
Rest$233.63M13.5%
Top 3 weight
31.7%
Top 10 weight
58.5%
Voting Authority Distribution
Total shares with voting rights: 76.91M
Sole
Full voting authority
76.91M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other49
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings49
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$373.49M
21.58%
Sole
8.49M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.02M
TypeSH
Market value$91.63M
5.29%
Sole
2.02M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares1.52M
TypeSH
Market value$84.16M
4.86%
Sole
1.52M
Shared
0.00
None
0.00
VAXCYTE INC
DFNDShares1.10M
TypeSH
Market value$83.06M
4.80%
Sole
1.10M
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
DFNDShares2.79M
TypeSH
Market value$75.43M
4.36%
Sole
2.79M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$72.43M
4.18%
Sole
8.32M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$68.39M
3.95%
Sole
2.94M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares1.35M
TypeSH
Market value$60.47M
3.49%
Sole
1.35M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares3.01M
TypeSH
Market value$54.15M
3.13%
Sole
3.01M
Shared
0.00
None
0.00
MERUS N V
DFNDShares840K
TypeSH
Market value$49.70M
2.87%
Sole
840K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.86M
TypeSH
Market value$47.07M
2.72%
Sole
1.86M
Shared
0.00
None
0.00
INSMED INC
DFNDShares675K
TypeSH
Market value$45.23M
2.61%
Sole
675K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares2.30M
TypeSH
Market value$44.18M
2.55%
Sole
2.30M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares1.05M
TypeSH
Market value$43.98M
2.54%
Sole
1.05M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares400K
TypeSH
Market value$32.20M
1.86%
Sole
400K
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares975K
TypeSH
Market value$30.78M
1.78%
Sole
975K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$29.73M
1.72%
Sole
2.91M
Shared
0.00
None
0.00
ALUMIS INC
DFNDShares2.15M
TypeSH
Market value$28.56M
1.65%
Sole
2.15M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares685K
TypeSH
Market value$28.33M
1.64%
Sole
685K
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares2.13M
TypeSH
Market value$28.16M
1.63%
Sole
2.13M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares801.96K
TypeSH
Market value$27.84M
1.61%
Sole
801.96K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
DFNDShares1.65M
TypeSH
Market value$27.69M
1.60%
Sole
1.65M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.47M
TypeSH
Market value$27.57M
1.59%
Sole
1.47M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares2.52M
TypeSH
Market value$23.48M
1.36%
Sole
2.52M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
DFNDShares125K
TypeSH
Market value$19.75M
1.14%
Sole
125K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $373.49M 21.58% | 8.49M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.02M | SH | $91.63M 5.29% | 2.02M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 1.52M | SH | $84.16M 4.86% | 1.52M | 0.00 | 0.00 |
VAXCYTE INCDFND | COM | 1.10M | SH | $83.06M 4.80% | 1.10M | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INDFND | COM | 2.79M | SH | $75.43M 4.36% | 2.79M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $72.43M 4.18% | 8.32M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 2.94M | SH | $68.39M 3.95% | 2.94M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 1.35M | SH | $60.47M 3.49% | 1.35M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 3.01M | SH | $54.15M 3.13% | 3.01M | 0.00 | 0.00 |
MERUS N VDFND | COM | 840K | SH | $49.70M 2.87% | 840K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.86M | SH | $47.07M 2.72% | 1.86M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 675K | SH | $45.23M 2.61% | 675K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 2.30M | SH | $44.18M 2.55% | 2.30M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 1.05M | SH | $43.98M 2.54% | 1.05M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 400K | SH | $32.20M 1.86% | 400K | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 975K | SH | $30.78M 1.78% | 975K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $29.73M 1.72% | 2.91M | 0.00 | 0.00 |
ALUMIS INCDFND | COM | 2.15M | SH | $28.56M 1.65% | 2.15M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 685K | SH | $28.33M 1.64% | 685K | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.13M | SH | $28.16M 1.63% | 2.13M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 801.96K | SH | $27.84M 1.61% | 801.96K | 0.00 | 0.00 |
UROGEN PHARMA LTDDFND | COM | 1.65M | SH | $27.69M 1.60% | 1.65M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.47M | SH | $27.57M 1.59% | 1.47M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 2.52M | SH | $23.48M 1.36% | 2.52M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCDFND | COM | 125K | SH | $19.75M 1.14% | 125K | 0.00 | 0.00 |
Page 1 of 2